Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Ciesek

Showing results (81-90 of 223) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|October 13, 2009
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin ASandra Ciesek, Eike Steinmann, Heiner Wedemeyer, et al.
European Journal of Immunology|June 23, 2026
Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior InfectionCaroline Diener, Rebecca Urschel, Saskia Bronder, et al.
Vaccines|July 27, 2022
Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster VaccinationKatharina Grikscheit, Holger F Rabenau, Zahra Ghodratian, et al.
Laryngo- Rhino- Otologie|May 29, 2020
[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic]Roxanne Weiss, Andreas Loth, Daniela Guderian, et al.
Transfusion|May 4, 2020
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmissionVictor M Corman, Holger F Rabenau, Ortwin Adams, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2023
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virusFabian Roesmann, Irene Jakobsche, Christiane Pallas, et al.
The Science of the Total Environment|August 30, 2020
Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risksSandra Westhaus, Frank-Andreas Weber, Sabrina Schiwy, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 28, 2019
Infectivity and stability of hepatitis C virus in different perfusion solutionsFabian A Helfritz, Verena Wanders, Denisa Bojkova, et al.
Frontiers in Immunology|February 12, 2021
Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver FailureSabrina Rueschenbaum, Sandra Ciesek, Alexander Queck, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 18, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term viewIvana von Metzler, Julia Campe, Sabine Huenecke, et al.
Pageof 23

Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|October 13, 2009
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin ASandra Ciesek, Eike Steinmann, Heiner Wedemeyer, et al.
European Journal of Immunology|June 23, 2026
Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior InfectionCaroline Diener, Rebecca Urschel, Saskia Bronder, et al.
Vaccines|July 27, 2022
Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster VaccinationKatharina Grikscheit, Holger F Rabenau, Zahra Ghodratian, et al.
Laryngo- Rhino- Otologie|May 29, 2020
[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic]Roxanne Weiss, Andreas Loth, Daniela Guderian, et al.
Transfusion|May 4, 2020
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmissionVictor M Corman, Holger F Rabenau, Ortwin Adams, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2023
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virusFabian Roesmann, Irene Jakobsche, Christiane Pallas, et al.
The Science of the Total Environment|August 30, 2020
Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risksSandra Westhaus, Frank-Andreas Weber, Sabrina Schiwy, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 28, 2019
Infectivity and stability of hepatitis C virus in different perfusion solutionsFabian A Helfritz, Verena Wanders, Denisa Bojkova, et al.
Frontiers in Immunology|February 12, 2021
Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver FailureSabrina Rueschenbaum, Sandra Ciesek, Alexander Queck, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 18, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term viewIvana von Metzler, Julia Campe, Sabine Huenecke, et al.
Pageof 23